Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Viral Nonstructural Proteins | 6 | 2021 | 45 | 2.680 |
Why?
|
| West Nile virus | 4 | 2021 | 65 | 1.880 |
Why?
|
| Virus Replication | 3 | 2021 | 261 | 0.800 |
Why?
|
| Encephalitis Virus, Japanese | 1 | 2020 | 5 | 0.750 |
Why?
|
| Flavivirus | 1 | 2020 | 10 | 0.740 |
Why?
|
| West Nile Fever | 1 | 2021 | 56 | 0.740 |
Why?
|
| Cross Reactions | 1 | 2020 | 83 | 0.730 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 252 | 0.630 |
Why?
|
| Computational Biology | 1 | 2016 | 275 | 0.470 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 101 | 0.460 |
Why?
|
| Vero Cells | 3 | 2020 | 90 | 0.440 |
Why?
|
| Dengue Virus | 2 | 2020 | 84 | 0.270 |
Why?
|
| Rhizobium | 1 | 2004 | 10 | 0.260 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2004 | 12 | 0.260 |
Why?
|
| Fabaceae | 1 | 2004 | 22 | 0.260 |
Why?
|
| Sigma Factor | 1 | 2004 | 17 | 0.250 |
Why?
|
| Endoplasmic Reticulum, Rough | 1 | 2021 | 3 | 0.200 |
Why?
|
| RNA Helicases | 1 | 2021 | 16 | 0.200 |
Why?
|
| Serine Endopeptidases | 1 | 2021 | 36 | 0.200 |
Why?
|
| Cytoplasm | 1 | 2021 | 135 | 0.190 |
Why?
|
| Protein Transport | 1 | 2021 | 286 | 0.180 |
Why?
|
| Immunoassay | 1 | 2020 | 57 | 0.180 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 102 | 0.180 |
Why?
|
| Monocytes | 2 | 2011 | 258 | 0.180 |
Why?
|
| Phylogeny | 2 | 2016 | 612 | 0.160 |
Why?
|
| Animals | 5 | 2020 | 14307 | 0.160 |
Why?
|
| Kava | 2 | 2007 | 6 | 0.150 |
Why?
|
| Cell Line | 4 | 2014 | 1289 | 0.150 |
Why?
|
| Humans | 8 | 2021 | 34853 | 0.140 |
Why?
|
| Sequence Analysis, Protein | 1 | 2016 | 49 | 0.140 |
Why?
|
| Cloning, Molecular | 1 | 2016 | 310 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 104 | 0.130 |
Why?
|
| Plasmids | 1 | 2016 | 233 | 0.130 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2014 | 35 | 0.120 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 249 | 0.120 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 210 | 0.120 |
Why?
|
| Antigen-Antibody Complex | 1 | 2011 | 19 | 0.110 |
Why?
|
| Phagocytosis | 1 | 2011 | 64 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2011 | 51 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2014 | 834 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 70 | 0.100 |
Why?
|
| Mutation | 1 | 2016 | 1023 | 0.100 |
Why?
|
| Cytokines | 2 | 2011 | 569 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 162 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2011 | 287 | 0.090 |
Why?
|
| Risperidone | 1 | 2008 | 5 | 0.090 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2008 | 16 | 0.090 |
Why?
|
| Calcium | 1 | 2011 | 445 | 0.080 |
Why?
|
| JC Virus | 1 | 2008 | 24 | 0.080 |
Why?
|
| Polyomavirus Infections | 1 | 2008 | 20 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2011 | 296 | 0.080 |
Why?
|
| Macrophages | 1 | 2011 | 431 | 0.080 |
Why?
|
| Neuroglia | 1 | 2008 | 117 | 0.080 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2007 | 9 | 0.080 |
Why?
|
| Alkaline Phosphatase | 1 | 2007 | 48 | 0.080 |
Why?
|
| Beverages | 1 | 2007 | 64 | 0.070 |
Why?
|
| Least-Squares Analysis | 1 | 2006 | 42 | 0.070 |
Why?
|
| Lactones | 1 | 2006 | 20 | 0.070 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2006 | 24 | 0.070 |
Why?
|
| Nitrogen Fixation | 1 | 2004 | 1 | 0.070 |
Why?
|
| Alternative Splicing | 1 | 2004 | 82 | 0.060 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2004 | 145 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 455 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 1490 | 0.050 |
Why?
|
| Plant Extracts | 2 | 2007 | 250 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2011 | 48 | 0.030 |
Why?
|
| Permeability | 1 | 2011 | 67 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 63 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 91 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2011 | 52 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 90 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2011 | 235 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 423 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2011 | 148 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 605 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2011 | 897 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 878 | 0.020 |
Why?
|
| Cell Survival | 1 | 2011 | 818 | 0.020 |
Why?
|
| Fetus | 1 | 2008 | 103 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2008 | 108 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2007 | 18 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2007 | 15 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2007 | 26 | 0.020 |
Why?
|
| Bilirubin | 1 | 2007 | 17 | 0.020 |
Why?
|
| Desiccation | 1 | 2006 | 10 | 0.020 |
Why?
|
| Powders | 1 | 2006 | 14 | 0.020 |
Why?
|
| Anti-Anxiety Agents | 1 | 2006 | 14 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 968 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 406 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 901 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 5668 | 0.010 |
Why?
|
| Hawaii | 1 | 2007 | 1878 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 5035 | 0.010 |
Why?
|
| Middle Aged | 1 | 2007 | 9642 | 0.010 |
Why?
|
| Adult | 1 | 2007 | 11034 | 0.010 |
Why?
|
| Male | 1 | 2007 | 18870 | 0.010 |
Why?
|
| Female | 1 | 2007 | 19873 | 0.010 |
Why?
|